BEAM Q1 2025 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+0.8% YoY

Gross Profit

-$91M-1222.8% margin

Operating Income

-$119M-1596.9% margin

Net Income

-$109M-1462.8% margin

EPS (Diluted)

$-1.24

QoQ Revenue Growth

-75.2%

Cash Flow

Operating Cash Flow

-$104M

Free Cash Flow

-$107M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$344M

Stockholders' Equity

$1.1B

Cash & Equivalents

$528M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$7M	+0.8%
Gross Profit	-$91M	-$77M	-18.0%
Operating Income	-$119M	-$104M	-14.6%
Net Income	-$109M	-$99M	-10.7%